Nrx pharmaceuticals, inc. (nasdaq:nrxp) announces up to $16 million senior secured debt financing from anson funds

This financing is expected to support 2024 filing of new drug applications fornrx-100 (ketamine) and nrx-101 and to support launch of hope therapeutics streeterville capital has agreed to a settlement of all claims to be paid from the proceeds of this financing radnor, pa. , aug. 13, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals" or the "company"), a clinical-stage biopharmaceutical company, today announced that it has obtained up to approximately $16 million in convertible debt financing (the "financing") from an institutional investor.
NRXP Ratings Summary
NRXP Quant Ranking